Mesirow Financial Investment Management, Inc. Halozyme Therapeutics, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.79 Billion
- Q4 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 19,494 shares of HALO stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,494
Previous 8,500
129.34%
Holding current value
$1.13 Million
Previous $486,000
91.77%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HALO
# of Institutions
545Shares Held
121MCall Options Held
419KPut Options Held
172K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$772 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$385 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$236 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.07MShares$178 Million0.05% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.09B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...